SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nigel P. Mongan, Rieko Tadokoro Cuccaro, Trevor Bunch, Ieuan A. Hughes, Androgen insensitivity syndrome, Best Practice & Research Clinical Endocrinology & Metabolism, 2015,

    CrossRef

  2. 2
    Khalid Saeed, Päivi Östling, Mari Björkman, Tuomas Mirtti, Kalle Alanen, Tiina Vesterinen, Anna Sankila, Johan Lundin, Mikael Lundin, Antti Rannikko, Stig Nordling, John-Patrick Mpindi, Pekka Kohonen, Kristiina Iljin, Olli Kallioniemi, Juha K. Rantala, Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions, International Journal of Cancer, 2015, 136, 11
  3. 3
    Jennifer Munkley, Nicholas P Lafferty, Gabriela Kalna, Craig N Robson, Hing Y Leung, Prabhakar Rajan, David J Elliott, Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells, BMC Cancer, 2015, 15, 1

    CrossRef

  4. 4
    Yashwanth Subbannayya, Nazia Syed, Mustafa A Barbhuiya, Remya Raja, Arivusudar Marimuthu, Nandini Sahasrabuddhe, Sneha M Pinto, Srikanth Srinivas Manda, Santosh Renuse, HC Manju, Mohammed Abdul Lateef Zameer, Jyoti Sharma, Mariana Brait, Kotteazeth Srikumar, Juan Carlos Roa, M Vijaya Kumar, KV Veerendra Kumar, TS Keshava Prasad, Girija Ramaswamy, Rekha Vijay Kumar, Akhilesh Pandey, Harsha Gowda, Aditi Chatterjee, Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma, Cancer Biology & Therapy, 2015, 16, 2, 336

    CrossRef

  5. 5
    Ali Naderi, Coagulation factor VII is regulated by androgen receptor in breast cancer, Experimental Cell Research, 2015, 331, 1, 239

    CrossRef

  6. 6
    Yi Xie, Takeo Nakanishi, Karthika Natarajan, Lowell Safren, Anne W. Hamburger, Arif Hussain, Douglas D. Ross, Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2015, 1849, 3, 317

    CrossRef

  7. 7
    C. E. Massie, I. Spiteri, H. Ross-Adams, H. Luxton, J. Kay, H. C. Whitaker, M. J. Dunning, A. D. Lamb, A. Ramos-Montoya, D. S. Brewer, C. S. Cooper, R. Eeles, A. Y. Warren, S. Tavare, D. E. Neal, A. G. Lynch, HES5 silencing is an early and recurrent change in prostate tumourigenesis, Endocrine Related Cancer, 2015, 22, 2, 131

    CrossRef

  8. 8
    Peder Rustøen Braadland, Håkon Ramberg, Helene Hartvedt Grytli, Kristin Austlid Taskén, β-Adrenergic Receptor Signaling in Prostate Cancer, Frontiers in Oncology, 2015, 4,

    CrossRef

  9. 9
    Hao FU, Hui-chan He, Zhao-dong Han, Yue-ping Wan, Hong-wei Luo, Ya-qiang Huang, Chao Cai, Yu-xiang Liang, Qi-shan Dai, Fu-neng Jiang, Wei-de Zhong, MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer, Tumor Biology, 2015, 36, 3, 1983

    CrossRef

  10. 10
    Qing-Shuo Zhang, Eric Benedetti, Matthew Deater, Kathryn Schubert, Angela Major, Carl Pelz, Soren Impey, Laura Marquez-Loza, R. Keaney Rathbun, Shigeaki Kato, Grover C. Bagby, Markus Grompe, Oxymetholone Therapy of Fanconi Anemia Suppresses Osteopontin Transcription and Induces Hematopoietic Stem Cell Cycling, Stem Cell Reports, 2015, 4, 1, 90

    CrossRef

  11. 11
    S. Toropainen, M. Malinen, S. Kaikkonen, M. Rytinki, T. Jaaskelainen, B. Sahu, O. A. Janne, J. J. Palvimo, SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin, Nucleic Acids Research, 2015, 43, 2, 848

    CrossRef

  12. 12
    S. C. Chan, L. A. Selth, Y. Li, M. D. Nyquist, L. Miao, J. E. Bradner, G. V. Raj, W. D. Tilley, S. M. Dehm, Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies, Nucleic Acids Research, 2015,

    CrossRef

  13. 13
    Petra Popovics, Daniel E Frigo, Andrew V Schally, Ferenc G Rick, Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer, Expert Opinion on Therapeutic Targets, 2015, 19, 5, 617

    CrossRef

  14. 14
    Ji Lu, Peter E. Lonergan, Lucas P. Nacusi, Liguo Wang, Lucy J. Schmidt, Zhifu Sun, Travis Van der Steen, Stephen A. Boorjian, Farhad Kosari, George Vasmatzis, George G. Klee, Steven P. Balk, Haojie Huang, Chunxi Wang, Donald J. Tindall, The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells, The Journal of Urology, 2015, 193, 2, 690

    CrossRef

  15. 15
    Sang-Min Jeon, Nissim Hay, The double-edged sword of AMPK signaling in cancer and its therapeutic implications, Archives of Pharmacal Research, 2015, 38, 3, 346

    CrossRef

  16. 16
    Steven M. Mooney, Princy Parsana, James R. Hernandez, Xin Liu, James E. Verdone, Gonzalo Torga, Calvin A. Harberg, Kenneth J. Pienta, The Presence of Androgen Receptor Elements Regulates ZEB1 Expression in the Absence of Androgen Receptor, Journal of Cellular Biochemistry, 2015, 116, 1
  17. 17
    H B Ragnum, L Vlatkovic, A K Lie, K Axcrona, C H Julin, K M Frikstad, K H Hole, T Seierstad, H Lyng, The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer, British Journal of Cancer, 2015, 112, 2, 382

    CrossRef

  18. 18
    Chiu-Lien Hung, Ling-Yu Wang, Yen-Ling Yu, Hong-Wu Chen, Shiv Srivastava, Gyorgy Petrovics, Hsing-Jien Kung, A long noncoding RNA connects c-Myc to tumor metabolism, Proceedings of the National Academy of Sciences, 2014, 111, 52, 18697

    CrossRef

  19. 19
    Ji-Young Kim, Taraswi Banerjee, Aurimas Vinckevicius, Qianyi Luo, J. Brandon Parker, Mairead R. Baker, Ishwar Radhakrishnan, Jian-Jun Wei, Grant D. Barish, Debabrata Chakravarti, A Role for WDR5 in Integrating Threonine 11 Phosphorylation to Lysine 4 Methylation on Histone H3 during Androgen Signaling and in Prostate Cancer, Molecular Cell, 2014, 54, 4, 613

    CrossRef

  20. 20
    Matthew J Schiewer, Karen E Knudsen, AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy, EMBO Molecular Medicine, 2014, 6, 4
  21. 21
    X Yuan, C Cai, S Chen, S Chen, Z Yu, S P Balk, Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis, Oncogene, 2014, 33, 22, 2815

    CrossRef

  22. 22
    S. J. Barfeld, H. M. Itkonen, A. Urbanucci, I. G. Mills, Androgen-regulated metabolism and biosynthesis in prostate cancer, Endocrine Related Cancer, 2014, 21, 4, T57

    CrossRef

  23. 23
    Y. Zhou, E. C. Bolton, J. O. Jones, Androgens and androgen receptor signaling in prostate tumorigenesis, Journal of Molecular Endocrinology, 2014, 54, 1, R15

    CrossRef

  24. 24
    J B Tennakoon, Y Shi, J J Han, E Tsouko, M A White, A R Burns, A Zhang, X Xia, O R Ilkayeva, L Xin, M M Ittmann, F G Rick, A V Schally, D E Frigo, Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch, Oncogene, 2014, 33, 45, 5251

    CrossRef

  25. 25
    Michael A. Augello, Robert B. Den, Karen E. Knudsen, AR function in promoting metastatic prostate cancer, Cancer and Metastasis Reviews, 2014, 33, 2-3, 399

    CrossRef

  26. 26
    L Wu, C Runkle, H-J Jin, J Yu, J Li, X Yang, T Kuzel, C Lee, J Yu, CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor, Oncogene, 2014, 33, 4, 504

    CrossRef

  27. 27
    Guang Han, Zbigniew P. Kortylewicz, Thomas Enke, Janina Baranowska-Kortylewicz, Co-targeting androgen receptor and DNA for imaging and molecular radiotherapy of prostate cancer: In vitro studies, The Prostate, 2014, 74, 16
  28. 28
    C.-L. Hsieh, T. Fei, Y. Chen, T. Li, Y. Gao, X. Wang, T. Sun, C. J. Sweeney, G.-S. M. Lee, S. Chen, S. P. Balk, X. S. Liu, M. Brown, P. W. Kantoff, Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation, Proceedings of the National Academy of Sciences, 2014, 111, 20, 7319

    CrossRef

  29. 29
    A. W. Nelson, W. D. Tilley, D. E. Neal, J. S. Carroll, Estrogen receptor beta in prostate cancer: friend or foe?, Endocrine Related Cancer, 2014, 21, 4, T219

    CrossRef

  30. 30
    Antonio Ramos-Montoya, Alastair D Lamb, Roslin Russell, Thomas Carroll, Sarah Jurmeister, Nuria Galeano-Dalmau, Charlie E Massie, Joan Boren, Helene Bon, Vasiliki Theodorou, Maria Vias, Greg L Shaw, Naomi L Sharma, Helen Ross-Adams, Helen E Scott, Sarah L Vowler, William J Howat, Anne Y Warren, Richard F Wooster, Ian G Mills, David E Neal, HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network, EMBO Molecular Medicine, 2014, 6, 5
  31. 31
    Eliza L. S. Fong, Mariane Martinez, Jun Yang, Antonios G. Mikos, Nora M. Navone, Daniel A. Harrington, Mary C. Farach-Carson, Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening, Molecular Pharmaceutics, 2014, 11, 7, 2040

    CrossRef

  32. 32
    Benjamin Sunkel, Qianben Wang, Looking beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer, Advances in Andrology, 2014, 2014, 1

    CrossRef

  33. 33
    Ian G. Mills, Maintaining and reprogramming genomic androgen receptor activity in prostate cancer, Nature Reviews Cancer, 2014, 14, 3, 187

    CrossRef

  34. 34
    Akash K. Kaushik, Shaiju K. Vareed, Sumanta Basu, Vasanta Putluri, Nagireddy Putluri, Katrin Panzitt, Christine A. Brennan, Arul M. Chinnaiyan, Ismael A. Vergara, Nicholas Erho, Nancy L. Weigel, Nicholas Mitsiades, Ali Shojaie, Ganesh Palapattu, George Michailidis, Arun Sreekumar, Metabolomic Profiling Identifies Biochemical Pathways Associated with Castration-Resistant Prostate Cancer, Journal of Proteome Research, 2014, 13, 2, 1088

    CrossRef

  35. 35
    Ummuhan Demir, Andrea Koehler, Rainer Schneider, Susann Schweiger, Helmut Klocker, Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells, BMC Cancer, 2014, 14, 1, 52

    CrossRef

  36. 36
    H C Whitaker, L L Shiong, J D Kay, H Grönberg, A Y Warren, A Seipel, F Wiklund, B Thomas, P Wiklund, J L Miller, S Menon, A Ramos-Montoya, S L Vowler, C Massie, L Egevad, D E Neal, N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype, Oncogene, 2014, 33, 45, 5274

    CrossRef

  37. 37
    Mani Roshan-Moniri, Michael Hsing, Miriam S. Butler, Artem Cherkasov, Paul S. Rennie, Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers, Cancer Treatment Reviews, 2014, 40, 10, 1137

    CrossRef

  38. 38
    F. M. Fioretti, A. Sita-Lumsden, C. L. Bevan, G. N. Brooke, Revising the role of the androgen receptor in breast cancer, Journal of Molecular Endocrinology, 2014, 52, 3, R257

    CrossRef

  39. 39
    P. Sutinen, M. Malinen, S. Heikkinen, J. J. Palvimo, SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner, Nucleic Acids Research, 2014, 42, 13, 8310

    CrossRef

  40. 40
    Luís Korrodi-Gregório, Joana Vieira Silva, Luís Santos-Sousa, Maria João Freitas, Juliana Felgueiras, Margarida Fardilha, TGF-β cascade regulation by PPP1 and its interactors –impact on prostate cancer development and therapy, Journal of Cellular and Molecular Medicine, 2014, 18, 4
  41. 41
    Jeffrey E Roth, Cody J Peer, Douglas K Price, William D Figg, The androgen receptor transcriptional program in castration-resistant prostate cancer, Cancer Biology & Therapy, 2014, 15, 1, 16

    CrossRef

  42. 42
    Min Shen, Zhen Zhang, Manohar Ratnam, Q. Ping Dou, The Interplay of AMP-Activated Protein Kinase and Androgen Receptor in Prostate Cancer Cells, Journal of Cellular Physiology, 2014, 229, 6
  43. You have free access to this content43
    Alastair D. Lamb, Charlie E. Massie, David E. Neal, The transcriptional programme of the androgen receptor (AR) in prostate cancer, BJU International, 2014, 113, 3
  44. 44
    D. Wu, B. Sunkel, Z. Chen, X. Liu, Z. Ye, Q. Li, C. Grenade, J. Ke, C. Zhang, H. Chen, K. P. Nephew, T. H.- M. Huang, Z. Liu, V. X. Jin, Q. Wang, Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer, Nucleic Acids Research, 2014, 42, 6, 3607

    CrossRef

  45. 45
    Päivi Pihlajamaa, Biswajyoti Sahu, Lauri Lyly, Viljami Aittomäki, Sampsa Hautaniemi, Olli A Jänne, Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs, The EMBO Journal, 2014, 33, 4
  46. 46
    H M Itkonen, N Engedal, E Babaie, M Luhr, I J Guldvik, S Minner, J Hohloch, M C Tsourlakis, T Schlomm, I G Mills, UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation, Oncogene, 2014,

    CrossRef

  47. 47
    Wei-Lin W. Wang, Martin Tenniswood, Vitamin D, intermediary metabolism and prostate cancer tumor progression, Frontiers in Physiology, 2014, 5,

    CrossRef

  48. 48
    Siu Chiu Chan, Scott M. Dehm, Pharmacology & Therapeutics of Constitutively Active Receptors, 2014,

    CrossRef

  49. 49
    Y. Y. Sung, E. Cheung, Androgen receptor co-regulatory networks in castration-resistant prostate cancer, Endocrine Related Cancer, 2013, 21, 1, R1

    CrossRef

  50. 50
    Bi-Dar Wang, Qi Yang, Kristin Ceniccola, Fernando Bianco, Ramez Andrawis, Thomas Jarrett, Harold Frazier, Steven R. Patierno, Norman H. Lee, Androgen Receptor-Target Genes in African American Prostate Cancer Disparities, Prostate Cancer, 2013, 2013, 1

    CrossRef

  51. 51
    Ayesha A. Shafi, Aihua E. Yen, Nancy L. Weigel, Androgen receptors in hormone-dependent and castration-resistant prostate cancer, Pharmacology & Therapeutics, 2013, 140, 3, 223

    CrossRef

  52. 52
    Mieke Van Hemelrijck, Karl Michaelsson, William G. Nelson, Norma Kanarek, Adrian Dobs, Elizabeth A. Platz, Sabine Rohrmann, Association of serum calcium with serum sex steroid hormones in men in NHANES III, The Aging Male, 2013, 16, 4, 151

    CrossRef

  53. 53
    Susana Ros, Almut Schulze, Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism, Cancer & Metabolism, 2013, 1, 1, 8

    CrossRef

  54. 54
    Luigi Racioppi, CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem, Trends in Molecular Medicine, 2013, 19, 2, 83

    CrossRef

  55. 55
    S. Ottaviani, G. N. Brooke, C. O'Hanlon-Brown, J. Waxman, S. Ali, L. Buluwela, Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells, Journal of Molecular Endocrinology, 2013, 51, 3, 301

    CrossRef

  56. 56
    James Robert Krycer, Andrew John Brown, Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013, 1835, 2, 219

    CrossRef

  57. 57
    Michael A. Augello, Craig J. Burd, Ruth Birbe, Christopher McNair, Adam Ertel, Michael S. Magee, Daniel E. Frigo, Kari Wilder-Romans, Mark Shilkrut, Sumin Han, Danielle L. Jernigan, Jeffry L. Dean, Alessandro Fatatis, Donald P. McDonnell, Tapio Visakorpi, Felix Y. Feng, Karen E. Knudsen, Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes, Journal of Clinical Investigation, 2013, 123, 1, 493

    CrossRef

  58. 58
    Mamneet Manghera, Renée N Douville, Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?, Retrovirology, 2013, 10, 1, 16

    CrossRef

  59. 59
    Harald Bull Ragnum, Kathrine Røe, Ruth Holm, Ljiljana Vlatkovic, Jahn Marthin Nesland, Eva-Katrine Aarnes, Anne Hansen Ree, Kjersti Flatmark, Therese Seierstad, Wolfgang Lilleby, Heidi Lyng, Hypoxia-Independent Downregulation of Hypoxia-Inducible Factor 1 Targets by Androgen Deprivation Therapy in Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, 2013, 87, 4, 753

    CrossRef

  60. 60
    Vincenza Conteduca, Giuseppe Di Lorenzo, Giovanni Bozza, Raffaele Ardito, Michele Aieta, Metabolic Syndrome as a Peculiar Target for Management of Prostate Cancer Patients, Clinical Genitourinary Cancer, 2013, 11, 3, 211

    CrossRef

  61. 61
    Y. Jin, S. Qu, M. Tesikova, L. Wang, A. Kristian, G. M. Maelandsmo, H. Kong, T. Zhang, C. Jeronimo, M. R. Teixeira, E. Yuca, I. Tekedereli, K. Gorgulu, N. Alpay, A. K. Sood, G. Lopez-Berestein, H. E. Danielsen, B. Ozpolat, F. Saatcioglu, Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer, Proceedings of the National Academy of Sciences, 2013, 110, 28, E2572

    CrossRef

  62. 62
    Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik, Colleen C. Nelson, New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication, International Journal of Cell Biology, 2013, 2013, 1

    CrossRef

  63. 63
    H C Whitaker, D Patel, W J Howat, A Y Warren, J D Kay, T Sangan, J C Marioni, J Mitchell, S Aldridge, H J Luxton, C Massie, A G Lynch, D E Neal, Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress, British Journal of Cancer, 2013, 109, 4, 983

    CrossRef

  64. 64
    T Karantanos, P G Corn, T C Thompson, Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches, Oncogene, 2013, 32, 49, 5501

    CrossRef

  65. 65
    Naomi L. Sharma, Charlie E. Massie, Antonio Ramos-Montoya, Vincent Zecchini, Helen E. Scott, Alastair D. Lamb, Stewart MacArthur, Rory Stark, Anne Y. Warren, Ian G. Mills, David E. Neal, The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man, Cancer Cell, 2013, 23, 1, 35

    CrossRef

  66. 66
    K. Coffey, L. Rogerson, C. Ryan-Munden, D. Alkharaif, J. Stockley, R. Heer, K. Sahadevan, D. O'Neill, D. Jones, S. Darby, P. Staller, A. Mantilla, L. Gaughan, C. N. Robson, The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover, Nucleic Acids Research, 2013, 41, 8, 4433

    CrossRef

  67. You have free access to this content67
    Marcelo G. Bonini, Benjamin N. Gantner, The multifaceted activities of AMPK in tumor progression—why the “one size fits all” definition does not fit at all?, IUBMB Life, 2013, 65, 11
  68. 68
    Marina Rigau, Mireia Olivan, Marta Garcia, Tamara Sequeiros, Melania Montes, Eva Colás, Marta Llauradó, Jacques Planas, Inés Torres, Juan Morote, Colin Cooper, Jaume Reventós, Jeremy Clark, Andreas Doll, The Present and Future of Prostate Cancer Urine Biomarkers, International Journal of Molecular Sciences, 2013, 14, 6, 12620

    CrossRef

  69. You have free access to this content69
    Ken-ichi Takayama, Satoshi Inoue, Transcriptional network of androgen receptor in prostate cancer progression, International Journal of Urology, 2013, 20, 8
  70. 70
    David Carling, Claire Thornton, Angela Woods, Matthew J. Sanders, AMP-activated protein kinase: new regulation, new roles?, Biochemical Journal, 2012, 445, 1, 11

    CrossRef

  71. 71
    Neil MacKinnon, Amjad P. Khan, Arul M. Chinnaiyan, Thekkelnaycke M. Rajendiran, Ayyalusamy Ramamoorthy, Androgen receptor activation results in metabolite signatures of an aggressive prostate cancer phenotype: an NMR-based metabonomics study, Metabolomics, 2012, 8, 6, 1026

    CrossRef

  72. 72
    Saara Lehmusvaara, Timo Erkkilä, Alfonso Urbanucci, Kati Waltering, Janne Seppälä, Antti Larjo, Vilppu J Tuominen, Jorma Isola, Paula Kujala, Harri Lähdesmäki, Antti Kaipia, Teuvo LJ Tammela, Tapio Visakorpi, Chemical castration and anti-androgens induce differential gene expression in prostate cancer, The Journal of Pathology, 2012, 227, 3
  73. 73
    Alok K Tewari, Galip Yardimci, Yoichiro Shibata, Nathan C Sheffield, Lingyun Song, Barry S Taylor, Stoyan G Georgiev, Gerhard A Coetzee, Uwe Ohler, Terrence S Furey, Gregory E Crawford, Phillip G Febbo, Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity, Genome Biology, 2012, 13, 10, R88

    CrossRef

  74. 74
    Harri Itkonen, Ian G. Mills, Chromatin binding by the androgen receptor in prostate cancer, Molecular and Cellular Endocrinology, 2012, 360, 1-2, 44

    CrossRef

  75. 75
    Zhou Zhu, Manli Shi, Wenyue Hu, Heather Estrella, Jon Engebretsen, Tim Nichols, David Briere, Natilie Hosea, Gerrit Los, Paul A Rejto, Andrea Fanjul, Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding, BMC Genomics, 2012, 13, 1, 355

    CrossRef

  76. 76
    Takashi Shima, Atsushi Mizokami, Toru Miyagi, Keiichi Kawai, Kouji Izumi, Misako Kumaki, Mitsuo Ofude, Jian Zhang, Evan T. Keller, Mikio Namiki, Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer, The Prostate, 2012, 72, 16
  77. 77
    Sean M. Hartig, Bin He, Justin Y. Newberg, Scott A. Ochsner, David S. Loose, Rainer B. Lanz, Neil J. McKenna, Benjamin M. Buehrer, Sean E. McGuire, Marco Marcelli, Michael A. Mancini, Feed-Forward Inhibition of Androgen Receptor Activity by Glucocorticoid Action in Human Adipocytes, Chemistry & Biology, 2012, 19, 9, 1126

    CrossRef

  78. 78
    Jung Kim, Jindan Yu, Interrogating genomic and epigenomic data to understand prostate cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1825, 2, 186

    CrossRef

  79. 79
    Ian G. Mills, Nuclear translocation and functions of growth factor receptors, Seminars in Cell & Developmental Biology, 2012, 23, 2, 165

    CrossRef

  80. 80
    A Urbanucci, B Sahu, J Seppälä, A Larjo, L M Latonen, K K Waltering, T L J Tammela, R L Vessella, H Lähdesmäki, O A Jänne, T Visakorpi, Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer, Oncogene, 2012, 31, 17, 2153

    CrossRef

  81. 81
    K. F. Decker, D. Zheng, Y. He, T. Bowman, J. R. Edwards, L. Jia, Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions, Nucleic Acids Research, 2012, 40, 21, 10765

    CrossRef

  82. 82
    G. C. Rivera-Gonzalez, A. P. Droop, H. J. Rippon, K. Tiemann, D. Pellacani, L. J. Georgopoulos, N. J. Maitland, Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance, Nucleic Acids Research, 2012, 40, 11, 4825

    CrossRef

  83. 83
    Jorma J. Palvimo, The androgen receptor, Molecular and Cellular Endocrinology, 2012, 352, 1-2, 1

    CrossRef

  84. 84
    Jennifer H. Gunter, Amy A. Lubik, Ian McKenzie, Michael Pollak, Colleen C. Nelson, The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer, Advances in Urology, 2012, 2012, 1

    CrossRef

  85. 85
    Michael A Augello, Theresa E Hickey, Karen E Knudsen, FOXA1: master of steroid receptor function in cancer, The EMBO Journal, 2011, 30, 19
  86. 86
    Hui Gao, Karin Dahlman-Wright, From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer, The EMBO Journal, 2011, 30, 13